Skip to main content
Securities offering could pull in $2.7M for Rosetta Genomics

A public offering of 1.9 million securities units has been priced by Rosetta Genomics in hopes of raising about $2.7 million. The proceeds will be used to support the company's operations and other general corporate functions.

Full Story: